BMS-JPM-2025-presentation.pdf

1、43rd Annual J.P.Morgan Healthcare ConferenceJanuary 13th,2025Christopher Boerner,Ph.D.,Board Chair and Chief Executive OfficerForward Looking Statements and Non-GAAP Financial Information2This presentation(as well as the oral statements made with respect to the information contained in this presenta

2、tion)contains statements about Bristol-Myers Squibb Companys(the“Company”)future financial results,plans,business development strategy,anticipated clinical trials,results and regulatory approvals that constitute forward-looking statements for purposes of the safe harbor provisions under the Private

3、Securities Litigation Reform Act of 1995.All statements that are not statements of historical facts are,or may be deemed to be,forward-looking statements.Actual results may differ materially from those expressed in,or implied by,these statements as a result of various factors,including,but not limit

4、ed to:(i)New laws and regulations,(ii)Our ability to obtain,protect and maintain market exclusivity rights and enforce patents and other intellectual property rights,(iii)Our ability to achieve expected clinical,regulatory and contractual milestones on expected timelines or at all,(iv)Difficulties o

5、r delays in the development and commercialization of new products,(v)Difficulties or delays in our clinical trials and the manufacturing,distribution and sale of our products,(vi)Adverse outcomes in legal or regulatory proceedings,(vii)Risks relating to acquisitions,divestitures,alliances,joint vent

6、ures and other portfolio actions and(viii)Political and financial instability,including changes in general economic conditions.These and other important factors are discussed in the Companys most recent annual report on Form 10-K and reports on Forms 10-Q and 8-K.These documents are available on the